Skip to main content
Top
Published in: Endocrine 3/2010

01-12-2010 | Original Article

Undiagnosed thyroid dysfunction, thyroid antibodies, and iodine excretion in a Mediterranean population

Authors: Anna Lucas, María Teresa Julián, Ana Cantón, Conxa Castell, Roser Casamitjana, Eva María Martínez-Cáceres, María Luisa Granada

Published in: Endocrine | Issue 3/2010

Login to get access

Abstract

The prevalence of thyroid dysfunction varies in different populations. The aim of this cross-sectional study was to analyze the prevalence of undiagnosed thyroid dysfunction and thyroid antibodies and their relationship with urine iodine excretion in a representative sample of 1,124 (55.5% women; mean age: 44.8 ± 15.2 years) non-hospitalized Mediterranean adults, in Catalonia (Spain). Free thyroxine, thyroid-stimulating hormone, thyroperoxidase and thyroglobulin antibodies, and urine iodine were measured. Undiagnosed thyroid dysfunction was 5.3% (hypothyroidism 3.8%; 56.66% of these subjects were women). The total (diagnosed + undiagnosed) thyroid dysfunction was 8.9% (71.15% women). Thyroperoxidase antibodies were positive in 2.4% of men and 9.4% of women and thyroglobulin antibodies, in 1.3% of men and 3.8% of women. No differences were observed in urine iodine between groups with thyroid dysfunction and euthyroidism, or between subjects with positive or negative antibodies. In subjects over 60, undiagnosed thyroid dysfunction was 9.8% (hypothyroidism 6.9%, hyperthyroidism 3.3%; 36.36% women) and total thyroid dysfunction 13.61% (53.12% women). Women and men over 60 had similar thyroid dysfunction prevalence. Thus, aggressive case-finding should be recommended in both, over 60.
Literature
1.
go back to reference S.H. Golden, K.A. Robinson, I. Saldanha, B. Anton, P.W. Ladenson, Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J. Clin. Endocrinol. Metab. 94, 1853–1878 (2009)CrossRefPubMed S.H. Golden, K.A. Robinson, I. Saldanha, B. Anton, P.W. Ladenson, Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J. Clin. Endocrinol. Metab. 94, 1853–1878 (2009)CrossRefPubMed
2.
go back to reference M.I. Surks, E. Ortiz, G.H. Daniels, C.T. Sawin, N.F. Col, R.H. Cobin, J.A. Franklyn, J.M. Hershman, K.D. Burman, M.A. Denke, C. Gorman, R.S. Cooper, N.J. Weissman, Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management. JAMA 291, 228–238 (2004)CrossRefPubMed M.I. Surks, E. Ortiz, G.H. Daniels, C.T. Sawin, N.F. Col, R.H. Cobin, J.A. Franklyn, J.M. Hershman, K.D. Burman, M.A. Denke, C. Gorman, R.S. Cooper, N.J. Weissman, Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management. JAMA 291, 228–238 (2004)CrossRefPubMed
3.
go back to reference M. Helfand, Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the US Preventive Services Task Force. Ann. Intern. Med. 140, 128–141 (2004)PubMed M. Helfand, Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the US Preventive Services Task Force. Ann. Intern. Med. 140, 128–141 (2004)PubMed
4.
go back to reference J.J. Corrales Hernández, N. Alonso Pedrol, A. Cantón Blanco, J.C. Galofré Ferrater, A. Pérez Pérez, T. Lajo Morales, B. Pérez Corral, F. Tortosa Henzi, Guía clínica del diagnóstico y tratamiento de la disfunción tiroidea subclínica. (Clinical practice guideline for the diagnosis and treatment of subclinical thyroid disease). Endocrinol. Nutr. 54, 44–52 (2007)CrossRef J.J. Corrales Hernández, N. Alonso Pedrol, A. Cantón Blanco, J.C. Galofré Ferrater, A. Pérez Pérez, T. Lajo Morales, B. Pérez Corral, F. Tortosa Henzi, Guía clínica del diagnóstico y tratamiento de la disfunción tiroidea subclínica. (Clinical practice guideline for the diagnosis and treatment of subclinical thyroid disease). Endocrinol. Nutr. 54, 44–52 (2007)CrossRef
5.
go back to reference P. Haentjens, A. Meerhaeghe, K. Poppe, B. Velkeniers, Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur. J. Endocrinol. 159, 329–341 (2008)CrossRefPubMed P. Haentjens, A. Meerhaeghe, K. Poppe, B. Velkeniers, Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur. J. Endocrinol. 159, 329–341 (2008)CrossRefPubMed
6.
go back to reference N. Ochs, R. Auer, C. Bauer, D. Nanchen, J. Gussekloo, J. Cornuz, N. Rodondi, Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann. Intern. Med. 148, 832–845 (2008)PubMed N. Ochs, R. Auer, C. Bauer, D. Nanchen, J. Gussekloo, J. Cornuz, N. Rodondi, Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann. Intern. Med. 148, 832–845 (2008)PubMed
7.
go back to reference B. Biondi, D.S. Cooper, The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 20, 76–131 (2008) B. Biondi, D.S. Cooper, The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 20, 76–131 (2008)
8.
go back to reference V. Fatourechi, Subclinical hypothyroidism: an update for primary physicians. Mayo Clin. Proc. 84, 65–71 (2009)CrossRefPubMed V. Fatourechi, Subclinical hypothyroidism: an update for primary physicians. Mayo Clin. Proc. 84, 65–71 (2009)CrossRefPubMed
9.
go back to reference J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, E.L. Braverman, Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002)CrossRefPubMed J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, E.L. Braverman, Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002)CrossRefPubMed
10.
go back to reference W.M. Tunbridge, D.C. Evered, R. Hall, D. Appleton, M. Brewis, F. Clark, J. Grimley, J. Evans, E. Young, T. Bird, P.A. Smith, The spectrum of thyroid disease in a community: the Whickham Survey. Clin. Endocrinol. (Oxf) 7, 481–493 (1977)CrossRef W.M. Tunbridge, D.C. Evered, R. Hall, D. Appleton, M. Brewis, F. Clark, J. Grimley, J. Evans, E. Young, T. Bird, P.A. Smith, The spectrum of thyroid disease in a community: the Whickham Survey. Clin. Endocrinol. (Oxf) 7, 481–493 (1977)CrossRef
11.
go back to reference M.P.J. Vanderpump, W.M.G. Tunbridge, Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 12, 839–847 (2002)CrossRefPubMed M.P.J. Vanderpump, W.M.G. Tunbridge, Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 12, 839–847 (2002)CrossRefPubMed
12.
go back to reference P. Valeix, C. Dos Santos, K. Castetbon, S. Bertrais, C. Cousty, S. Hercberg, Statut thyroïdien et fréquences des dysthyroïdies chez les adultes inclus dans l’étude SU.VI.MAX en 1994–1995. [Thyroid hormone levels and thyroid dysfunction of French adults participating in the SU.VI.MAX. study (1994–1995)]. Ann. Endocrinol. (Paris) 65, 477–486 (2004) P. Valeix, C. Dos Santos, K. Castetbon, S. Bertrais, C. Cousty, S. Hercberg, Statut thyroïdien et fréquences des dysthyroïdies chez les adultes inclus dans l’étude SU.VI.MAX en 1994–1995. [Thyroid hormone levels and thyroid dysfunction of French adults participating in the SU.VI.MAX. study (1994–1995)]. Ann. Endocrinol. (Paris) 65, 477–486 (2004)
13.
go back to reference T. Bjoro, J. Holmen, O. Krüger, K. Midthjell, K. Hunstad, T. Schreiner, L. Sandnes, H. Brochmann, Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur. J. Endocrinol. 143, 639–647 (2000)CrossRefPubMed T. Bjoro, J. Holmen, O. Krüger, K. Midthjell, K. Hunstad, T. Schreiner, L. Sandnes, H. Brochmann, Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur. J. Endocrinol. 143, 639–647 (2000)CrossRefPubMed
14.
go back to reference G.J. Canaris, N.R. Manowitz, G. Mayor, E.C. Ridgway, The Colorado thyroid disease prevalence study. Arch. Intern. Med. 160, 526–534 (2000)CrossRefPubMed G.J. Canaris, N.R. Manowitz, G. Mayor, E.C. Ridgway, The Colorado thyroid disease prevalence study. Arch. Intern. Med. 160, 526–534 (2000)CrossRefPubMed
15.
go back to reference P.C. O’Leary, P.H. Feddema, V.P. Michelangeli, P.J. Leedman, G.T. Chew, M. Knuiman, J. Kaye, J.P. Walsh, Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin. Endocrinol. (Oxf) 64, 97–104 (2006)CrossRef P.C. O’Leary, P.H. Feddema, V.P. Michelangeli, P.J. Leedman, G.T. Chew, M. Knuiman, J. Kaye, J.P. Walsh, Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin. Endocrinol. (Oxf) 64, 97–104 (2006)CrossRef
16.
go back to reference N. Konno, H. Makita, K. Yuri, N. Iizuka, K. Kawasaki, Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J. Clin. Endocrinol. Metab. 78, 393–397 (1994)CrossRefPubMed N. Konno, H. Makita, K. Yuri, N. Iizuka, K. Kawasaki, Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J. Clin. Endocrinol. Metab. 78, 393–397 (1994)CrossRefPubMed
17.
go back to reference N. Knudsen, T. Jorgensen, S. Rasmussen, E. Christiansen, H. Perrild, The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin. Endocrinol. (Oxf) 51, 361–367 (1999)CrossRef N. Knudsen, T. Jorgensen, S. Rasmussen, E. Christiansen, H. Perrild, The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin. Endocrinol. (Oxf) 51, 361–367 (1999)CrossRef
18.
go back to reference F. Aghini-Lombardi, L. Antonangeli, E. Martino, P. Vitti, D. Maccherini, F. Leoli, T. Rago, L. Grasso, R. Valeriano, A. Balestrieri, A. Pinchera, The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano Survey. J. Clin. Endocrinol. Metab. 84, 561–566 (1999)CrossRefPubMed F. Aghini-Lombardi, L. Antonangeli, E. Martino, P. Vitti, D. Maccherini, F. Leoli, T. Rago, L. Grasso, R. Valeriano, A. Balestrieri, A. Pinchera, The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano Survey. J. Clin. Endocrinol. Metab. 84, 561–566 (1999)CrossRefPubMed
19.
go back to reference N. Konno, K. Yuri, H. Taguchi, K. Miura, S. Taguchi, K. Hagiwara, S. Murakami, Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin. Endocrinol. 38, 273–281 (1993)CrossRef N. Konno, K. Yuri, H. Taguchi, K. Miura, S. Taguchi, K. Hagiwara, S. Murakami, Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin. Endocrinol. 38, 273–281 (1993)CrossRef
20.
go back to reference A. Alsayed, A.M. Gad, H. Abdel-Baset, A. Abdel-Fattah, A. Ahmed, A. Azab, Excess urinary iodine is associated with autoimmune subclinical hypothyroidism among Egyptian women. Endocr. J. 55, 601–605 (2008)CrossRefPubMed A. Alsayed, A.M. Gad, H. Abdel-Baset, A. Abdel-Fattah, A. Ahmed, A. Azab, Excess urinary iodine is associated with autoimmune subclinical hypothyroidism among Egyptian women. Endocr. J. 55, 601–605 (2008)CrossRefPubMed
21.
go back to reference P. Laurberg, C. Cerqueira, L. Ovesen, L.B. Rasmussen, H. Perrild, S. Andersen, I.B. Pedersen, A. Carlé, Iodine intake as a determinant of thyroid disorders in populations. Best. Pract. Res. Clin. Endocrinol. Metab. 24, 13–27 (2010)CrossRefPubMed P. Laurberg, C. Cerqueira, L. Ovesen, L.B. Rasmussen, H. Perrild, S. Andersen, I.B. Pedersen, A. Carlé, Iodine intake as a determinant of thyroid disorders in populations. Best. Pract. Res. Clin. Endocrinol. Metab. 24, 13–27 (2010)CrossRefPubMed
22.
go back to reference S. Juncà, M. Guillén, J.M. Aragay, P. Brugulat, C. Castell, E. Séculi, A. Medina, R. Tresserras, Aspectos metodológicos de la evaluación de los objetivos de salud y disminución de riesgo del Plan de Salud de Cataluña para el año 2000. (Methodological aspects in the evaluation of health and risk-reduction objectives of Health Plan for Catalonia for the year 2000). Med. Clin. (Barc) 121, 10–19 (2003) S. Juncà, M. Guillén, J.M. Aragay, P. Brugulat, C. Castell, E. Séculi, A. Medina, R. Tresserras, Aspectos metodológicos de la evaluación de los objetivos de salud y disminución de riesgo del Plan de Salud de Cataluña para el año 2000. (Methodological aspects in the evaluation of health and risk-reduction objectives of Health Plan for Catalonia for the year 2000). Med. Clin. (Barc) 121, 10–19 (2003)
23.
go back to reference P.S. Levy, S. Lemeshow, Sampling of Populations: Methods and Applications, 3rd edn. (Wiley, New York, 1999) P.S. Levy, S. Lemeshow, Sampling of Populations: Methods and Applications, 3rd edn. (Wiley, New York, 1999)
24.
go back to reference L. Salleras, R. Tresserras, Evaluación de los objetivos del Plan de Salud de Cataluña para el año 2000. (Decade assessment. Summary of evaluation of the objectives of the Health Plan for Catalonia for the year 2000). Med. Clin. (Barc) 121, 1–142 (2003)CrossRef L. Salleras, R. Tresserras, Evaluación de los objetivos del Plan de Salud de Cataluña para el año 2000. (Decade assessment. Summary of evaluation of the objectives of the Health Plan for Catalonia for the year 2000). Med. Clin. (Barc) 121, 1–142 (2003)CrossRef
25.
go back to reference S. Wilson, J.V. Parle, L.M. Roberts, A.K. Roalfe, F.D. Hobbs, P. Clark, M.C. Sheppard, M.D. Gammage, H.M. Pattison, J.A. Franklyn, Birmingham Elderly Thyroid Study Team, Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey. J. Clin. Endocrinol. Metab. 91, 4809–4816 (2006)CrossRefPubMed S. Wilson, J.V. Parle, L.M. Roberts, A.K. Roalfe, F.D. Hobbs, P. Clark, M.C. Sheppard, M.D. Gammage, H.M. Pattison, J.A. Franklyn, Birmingham Elderly Thyroid Study Team, Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey. J. Clin. Endocrinol. Metab. 91, 4809–4816 (2006)CrossRefPubMed
26.
go back to reference J.J. Díez, I. Molina, M.T. Ibars, Prevalence of thyroid dysfunction in adults over age 60 years from an urban community. Exp. Clin. Endocrinol. Diab. 111, 480–485 (2003)CrossRef J.J. Díez, I. Molina, M.T. Ibars, Prevalence of thyroid dysfunction in adults over age 60 years from an urban community. Exp. Clin. Endocrinol. Diab. 111, 480–485 (2003)CrossRef
27.
go back to reference M.J. Sender Palacios, M. Vernet Vernet, S. Pérez López, M. Faro Colomés, M. Rojas Blanc, L. Pallisa Gabriel, Enfermedad funcional tiroidea en la población de edad avanzada. (Functional thyroid pathology in the elderly). Aten. Primaria 34, 192–197 (2004)CrossRefPubMed M.J. Sender Palacios, M. Vernet Vernet, S. Pérez López, M. Faro Colomés, M. Rojas Blanc, L. Pallisa Gabriel, Enfermedad funcional tiroidea en la población de edad avanzada. (Functional thyroid pathology in the elderly). Aten. Primaria 34, 192–197 (2004)CrossRefPubMed
28.
go back to reference M.I. Surks, J.G. Hollowell, Age-specific distribution of serum thyrotropin and thyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 92, 4575–4582 (2007)CrossRefPubMed M.I. Surks, J.G. Hollowell, Age-specific distribution of serum thyrotropin and thyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 92, 4575–4582 (2007)CrossRefPubMed
29.
go back to reference E.H. Hoogendoorn, A.R. Hermus, F. de Vegt, H.A. Ross, A.L. Verbeek, L.A. Kiemeney, D.W. Swinkels, F.C. Sweep, M. den Heijer, Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin. Chem. 52, 104–111 (2006)CrossRefPubMed E.H. Hoogendoorn, A.R. Hermus, F. de Vegt, H.A. Ross, A.L. Verbeek, L.A. Kiemeney, D.W. Swinkels, F.C. Sweep, M. den Heijer, Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin. Chem. 52, 104–111 (2006)CrossRefPubMed
30.
go back to reference F. Delange, B. de Benoist, H. Burgi, Determining median urinary iodine concentration that indicates adequate iodine intake at population level. Bull. World Health Organ. 80, 633–636 (2002)PubMed F. Delange, B. de Benoist, H. Burgi, Determining median urinary iodine concentration that indicates adequate iodine intake at population level. Bull. World Health Organ. 80, 633–636 (2002)PubMed
31.
go back to reference J.E. Haddow, M.R. McClain, G.E. Palomaki, J.G. Hollowell, Urine iodine measurements, creatinine adjustment, and thyroid deficiency in an adult United States population. J. Clin. Endocrinol. Metab. 92, 1019–1022 (2007)CrossRefPubMed J.E. Haddow, M.R. McClain, G.E. Palomaki, J.G. Hollowell, Urine iodine measurements, creatinine adjustment, and thyroid deficiency in an adult United States population. J. Clin. Endocrinol. Metab. 92, 1019–1022 (2007)CrossRefPubMed
32.
go back to reference A. Tomer, T.F. Davies, Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 24, 694–717 (2003)CrossRefPubMed A. Tomer, T.F. Davies, Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 24, 694–717 (2003)CrossRefPubMed
33.
go back to reference M. Empson, V. Flood, G. Ma, C.J. Eastman, P. Mitchell, Prevalence of thyroid disease in an older Australian population. Intern. Med. J. 37, 448–455 (2007)CrossRefPubMed M. Empson, V. Flood, G. Ma, C.J. Eastman, P. Mitchell, Prevalence of thyroid disease in an older Australian population. Intern. Med. J. 37, 448–455 (2007)CrossRefPubMed
Metadata
Title
Undiagnosed thyroid dysfunction, thyroid antibodies, and iodine excretion in a Mediterranean population
Authors
Anna Lucas
María Teresa Julián
Ana Cantón
Conxa Castell
Roser Casamitjana
Eva María Martínez-Cáceres
María Luisa Granada
Publication date
01-12-2010
Publisher
Springer US
Published in
Endocrine / Issue 3/2010
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-010-9397-2

Other articles of this Issue 3/2010

Endocrine 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine